Headache and Cortisol Responses to M-Chlorophenylpiperazine are Highly Correlated

Cephalalgia

Volumn 13, Issue 6, 1993, Pages 400-405

  Gordon, Marc L ^a   Lipton, Richard B ^b   Brown, Serena Lynn ^b   Nakraseive, Christina ^b   Korn, Martin l ^b   Merriam, Arnold ^b   Russell, Marjorie ^c   Solomon, Seymour ^c   Pollack, Simcha z ^d   Praag, Herman M Van ^e  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d ST JOHN'S UNIVERSITY   (United States)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hydrocortisone; m chlorophenylpiperazine; migraine; receptors serotonin; serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; HYDROCORTISONE; PIPERAZINE DERIVATIVE; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; MALE;

ADULT; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; HYDROCORTISONE; MALE; MIGRAINE DISORDERS; PIPERAZINES; PLACEBOS; PROLACTIN; REFERENCE VALUES; SEROTONIN AGONISTS;

EID: 0027724156     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1993.1306400.x     Document Type: Article

References (22)

1. Gordon ML, et al Serotonergic parallels in migraine, depression, and anxiety. In: Nappi G, eds Headache and depression: serotonin pathways as a common clue. New York: Raven Press, 1991: 21–40
2. Raskin NH Headache. 2nd ed. New York: Churchill Living-stone, 1988: 104–10
3. Sicuteri F Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache 1972; 12: 69–72
4. Fuller RW Serotonin receptors and neuroendocrine responses. Neuropsychopharmacology 1990; 3: 495–502
5. Van de Kar LD Carnes M Maslowski RJ, et al Neuroendocrine evidence for denervation supersensitivity of serotonin receptors: effects of the 5-HT agonist RU 24969 on corticotropin, corticosterone, prolactin and renin secretion. J Pharmacol Exp Ther 1989; 251: 428–34
6. Caccia S Ballabio M Samanin R m-Chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 1981; 33: 477–8
7. Samanin R Mennini T Ferraris A Bendotti C Borsini F Garattini S m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedeberg's Arch Pharmacol 1979; 308: 159–63
8. Fuller RW Snoddy HD Mason NR Owen JE Disposition and pharmacologic effects of m-chlorophenylpiperazine in rats. Neuropharmacology 1981; 20: 55–62
9. Invernizzi R Cotecchia S DeBlasi A Mennini T Pataccini R Samanin R Effects of m-chlorophenylpiperazine on re-ceptor binding and brain metabolism of monamines in rats. Neurochem Int 1981; 3: 239–44
10. Hamik A Peroutka SJ 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in human brain. Biol Psychiatry 1989; 25: 569–75
11. Kilpatrick GJ Jones BJ Tyers MB Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 1987; 330: 746–8
12. Mueller EA Murphy DL Sunderland T Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 1985; 61: 1179–84
13. Mueller EA Murphy DL Sunderland T Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 1986; 89: 388–91
14. Charney DS Woods SW Goodman WK Heninger GR Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 1987; 92: 14–24
15. Aloi JA Insel TR Mueller EA Murphy DL Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci 1984; 34: 1325–31
16. Quattrone A Tedeschi G Aguglia U Scopacasa F DiRenzo GF Annunziato L Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxy-tryptaminergic neurons. Studies with fenfluramine. Br J Clin Pharmacol 1983; 16: 471–5
17. Aulakh CS Hill JL Murphy DL Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 1992; 263: 588–95
18. Brewerton TD Murphy DL Mueller EA Jimerson DC Induction of migraine-like headaches by the serotonin agonist m-chlorophenylpiperazine. Clin Pharmacol Ther 1988; 43: 605–9
19. Spitzer RL Williams JBW Gibbon M Structured Clinical Interview for DSM-III-R-non-patient Version (SCID-NP, 5/1/89). New York: Biometrics Research Department, New York State Psychiatric Institute, 1989
20. Brewerton TD Murphy DL Lesem MD Brandt HA Jimerson DC Headache responses following m-chlorophenyl-piperazine in bulimics and controls. Headache 1992; 32: 217–22
21. Fozard JR Gray JA 5 HT1C receptor activation: a key step in the initiation of migraine? Trends Pharmacol Sci 1989; 10: 307–9
22. Spierings ELH Hypothesis: serotonin-1C receptor activation in migraine: an alternative point of view with therapeutic implication. Headache 1991: 31: 546–9